Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2026-05-07 @ 9:48 AM
Study NCT ID:
NCT00782106
Status:
COMPLETED
Last Update Posted:
2021-05-05
First Post:
2008-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously
Sponsor:
Baxalta now part of Shire
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
160602
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None